Literature DB >> 25386931

H7N9: preparing for the unexpected in influenza.

Daniel B Jernigan1, Nancy J Cox.   

Abstract

In the years prior to 2013, avian influenza A H7 viruses were a cause of significant poultry mortality; however, human illness was generally mild. In March 2013, a novel influenza A(H7N9) virus emerged in China as an unexpected cause of severe human illness with 36% mortality. Chinese and other public health officials responded quickly, characterizing the virus and identifying more than 400 cases through use of new technologies and surveillance tools made possible by past preparedness and response efforts. Genetic sequencing, glycan-array receptor-binding assays, and ferret studies reveal the H7N9 virus to have increased binding to mammalian respiratory cells and to have mutations associated with higher virus replication rates and illness severity. New risk-assessment tools indicate H7N9 has the potential for further mammalian adaptation with possible human-to-human transmission. Vigilant virologic and epidemiologic surveillance is needed to monitor H7N9 and detect other unexpected novel influenza viruses that may emerge.

Entities:  

Keywords:  emerging infection; preparedness; risk assessment; sequencing

Mesh:

Year:  2014        PMID: 25386931     DOI: 10.1146/annurev-med-010714-112311

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  26 in total

Review 1.  Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure-function relationships.

Authors:  John F Cipollo; Lisa M Parsons
Journal:  Mass Spectrom Rev       Date:  2020-04-29       Impact factor: 10.946

2.  Adenovirus delivery of encoded monoclonal antibody protects against different types of influenza virus infection.

Authors:  Xiang Wang; Ping Zhou; Mangteng Wu; Kaiyan Yang; Jingao Guo; Xuchen Wang; Jun Li; Zihao Fang; Guiqin Wang; Man Xing; Dongming Zhou
Journal:  NPJ Vaccines       Date:  2020-07-09       Impact factor: 7.344

3.  Avian and Human Seasonal Influenza Hemagglutinin Proteins Elicit CD4 T Cell Responses That Are Comparable in Epitope Abundance and Diversity.

Authors:  Anthony DiPiazza; Katherine Richards; Nicholas Poulton; Andrea J Sant
Journal:  Clin Vaccine Immunol       Date:  2017-03-06

Review 4.  Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus.

Authors:  Zhu Guo; Jason R Wilson; Ian A York; James Stevens
Journal:  J Immunol Methods       Date:  2018-07-24       Impact factor: 2.303

Review 5.  Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities.

Authors:  Shelan Liu; Min Kang; Na Zhao; Yali Zhuang; Shijian Li; Tie Song
Journal:  Med Rev (Berl)       Date:  2022-05-25

6.  H5N1 influenza virulence, pathogenicity and transmissibility: what do we know?

Authors:  Gabriele Neumann
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

7.  Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.

Authors:  Hongquan Wan; Li Qi; Jin Gao; Laura K Couzens; Lianlian Jiang; Yamei Gao; Zong-Mei Sheng; Sharon Fong; Megan Hahn; Surender Khurana; Jeffery K Taubenberger; Maryna C Eichelberger
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

8.  H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.

Authors:  Jørgen de Jonge; Irina Isakova-Sivak; Harry van Dijken; Sanne Spijkers; Justin Mouthaan; Rineke de Jong; Tatiana Smolonogina; Paul Roholl; Larisa Rudenko
Journal:  Mol Ther       Date:  2016-01-22       Impact factor: 11.454

Review 9.  Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic.

Authors:  William J Liu; Haixia Xiao; Lianpan Dai; Di Liu; Jianjun Chen; Xiaopeng Qi; Yuhai Bi; Yi Shi; George F Gao; Yingxia Liu
Journal:  Front Med       Date:  2021-04-16       Impact factor: 4.592

10.  Influenza A(H7N9) virus acquires resistance-related neuraminidase I222T substitution when infected mallards are exposed to low levels of oseltamivir in water.

Authors:  Anna Gillman; Marie Nykvist; Shaman Muradrasoli; Hanna Söderström; Michelle Wille; Annika Daggfeldt; Caroline Bröjer; Jonas Waldenström; Björn Olsen; Josef D Järhult
Journal:  Antimicrob Agents Chemother       Date:  2015-06-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.